CRE-ating Success: Optimizing Antibiotic Therapy for Carbapenem-Resistant Enterobacterales Bacteremia

In this educational program, learn from expert faculty about developing individualized treatment plans for patients with carbapenem-resistant Enterobacterales (CRE) bacteremia, including interpretation of rapid diagnostic results, appropriate utilization of CRE-active agents based on IDSA guidance, and dose optimization strategies. Reinforce your learning with the downloadable infographic on antibiotic selection for CRE infections based on detected resistance genes.

Share

Program Content

Activities

CRE Treatment
How to Treat Infections Caused by CRE
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: October 16, 2023

Activities

CRE Bacteremia Treatment
CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2023

Expires: December 07, 2024

Activities

CRE Bacteremia Treatment
CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2023

Faculty

cover img faculity

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from bioMérieux, Inc.

bioMérieux, Inc.